UPDATE: Bank of America Merrill Lynch Initiates Coverage on Mylan with Overweight Rating
In a report published Monday, Bank of America Merrill Lynch initiated coverage on Mylan (NASDAQ: MYL) with an Overweight rating.
BofA Merrill Lynch noted, “We initiate coverage on Mylan at OW-100%, as we see material yield and promising long-term growth prospects vs. peers within the IG Pharma subsector. Moody's and S&P upgraded Mylan to investment grade last week mainly due to its strong positioning in the generics market and favorable financial policies.”
Mylan closed on Friday at $27.11.
Latest Ratings for MYL
|Dec 2015||Goldman Sachs||Upgrades||Buy||Conviction Buy|
|Dec 2015||Morgan Stanley||Assumes||Equal-weight|
|Nov 2015||Leerink Swann||Maintains||Outperform|
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.